AVANT Says No Avastin Benefit in Stage III Colon Cancer

A second randomized clinical trial has confirmed what the first one found — adding Avastin to standard chemotherapy does not reduce recurrences after surgery for stage III colon cancer. The AVANT trial compared standard FOLFOX chemotherapy to either FOLFOX plus…  Read More

Second Avastin Trial Shows No Benefit in Early Stage Colon Cancer

Adding Avastin® (bevacizumab) to chemotherapy for early stage colon cancer didn’t reduce the risk that cancer would return. In fact, preliminary results of the AVANT trial found that chemotherapy alone worked better in preventing recurrences of stage III and high-risk…  Read More

Afinitor Combined with Avastin Promises Help for Advanced Colorectal Cancer

Some colorectal cancer patients whose tumors had gotten worse on all standard treatments benefited from a combination of Afinitor® (everolimus) and Avastin® (bevacizumab) during a small trial reported at the 2010 ASCO Annual meeting in Chicago. While no tumors got…  Read More

Avastin Helps Patients Maintain Chemotherapy Effectiveness

It doesn’t hurt to stop XELOX chemotherapy combined with Avastin after six treatments and continue with Avastin alone until colorectal cancer gets worse, according to a study reported at the 2010 Annual Meeting of the American Society of Clinical Oncology…  Read More

Continuing Avastin after Colorectal Cancer Gets Worse Increases Survival Time

Colorectal cancer patients benefited when they continued to include Avastin® (bevacizumab) in their chemotherapy plan after their cancer got worse after initial treatment. They lived longer after beginning a second round of chemotherapy with Avastin than did other patients who…  Read More

Avastin Effective for Older Patients

Colorectal cancer patients 65 and older without other serious medical problems benefitted when Avastin® (bevacizumab) was added to chemotherapy. Combining results of four randomized clinical trials of Avastin and chemotherapy in patients with advanced colorectal cancer, researchers found that adding…  Read More